4 Results for "

PDK-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PDK-IN-2" in MCE Product Catalog:

Cat. No.: HY-156109
CAS No.: 3032446-61-7
Research Areas:  

Cancer

PDK-IN-2 (Compound 1F) is a PDK inhibitor (IC50: 68 nM). PDK-IN-2 inhibits the cellular expression of PDK1 and PDK4. PDK-IN-2 enhances mitochondrial bioenergetics, attenuates glycolytic phenotypes, and induces cell apoptosis in the mitochondrial pathway. PDK-IN-2 inhibits tumor growth in 4T1 syngeneic mice model .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12492
CAS No.: 1684386-71-7
Purity:  99.10%
Target:  

PDHK

Research Areas:  

Cancer

VER-246608 is a potent and ATP-competitive inhibitor of pyruvate dehydrogenase kinase (PDK) with IC50s of 35 nM, 40 nM, 84 nM, and 91 nM for PDK-1, PDK-3, PDK-2, and PDK-4, respectively.
loading...
    loading...
Cat. No.: HY-149275
CAS No.: 3041957-90-5
Research Areas:  

Cancer

PKM2/PDK1-IN-1, one of shikonin thioether derivatives, is a dual inhibitor of PKM2/PDK1. PKM2/PDK1-IN-1 inhibits the proliferation of NSCLC cells, and induces apoptosis. PKM2/PDK1-IN-1 induces intercellular ROS production, and regulates the apoptotic proteins, to involves in mitochondrial and death receptor pathway .
loading...
    loading...
Cat. No.: HY-146978
CAS No.: 2490699-44-8
Target:  

PDK-1

Research Areas:  

Cancer

LDHA/PDKs-IN-2 (compound 20k) is a potent and dual inhibitor of PDKs and LDHA with IC50s of 1.6 and 0.7 μM, respectively. LDHA/PDKs-IN-2 reduces A549 cell proliferation with an EC50 of 15.7 μM and decreases the lactate formation, and increases oxygen consumption. LDHA/PDKs-IN-2 has the potential for the research of cancer diseases .
loading...
    loading...